Effect of bladder filling on doses to prostate and organs at risk: A treatment planning study

Journal of Applied Clinical Medical Physics

Volumn 8, Issue 1, 2007, Pages 55-68

  Moiseenko, Vitali ^a   Liu, Mitchell ^a   Kristensen, Sarah ^a   Gelowitz, Gerald ^a   Berthelet, Eric ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Bladder filling; Organ motion; Prostate cancer; Radiotherapy

Indexed keywords

EID: 34247494807     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v8i1.2286     Document Type: Article

References (24)

1. Zellars RC, Roberson PL, Strawderman M, et al. Prostate position late in the course of external beam therapy: patterns and predictors. Int J Radiat Oncol Biol Phys. 2000;47(3):655-660.
2. Melian E, Mageras GS, Fuks Z, et al. Variation in prostate position quantitation and implications for three-dimensional conformal treatment planning. Int J Radiat Oncol Biol Phys. 1997;38(1):73-81.
3. Schild SE, Casale HE, Bellefontaine LP. Movements of the prostate due to rectal and bladder distension: implications for radiotherapy. Med Dosim. 1993;18(1):13-15.
4. Ten Haken RK, Forman JD, Heimburger DK, et al. Treatment planning issues related to prostate movement in response to differential filling of the rectum and bladder. Int J Radiat Oncol Biol Phys. 1991;20(6):1317-1324.
5. Zelefsky MJ, Crean D, Mageras GS, et al. Quantification and predictors of prostate position variability in 50 patients evaluated with multiple CT scans during conformal radiotherapy. Radiother Oncol. 1999;50(2):225-234.
6. Zelefsky MJ, Fuks Z, Happersett L, et al. Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol. 2000;55(3):241-249.
7. Zelefsky MJ, Fuks Z, Hunt M, et al. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer. J Urol. 2001;166(3):876-881. [Erratum in: J Urol. 2001;166(5):1839]
8. Antolak JA, Rosen II, Childress CH, Zagars GK, Pollack A. Prostate target volume variations during a course of radiotherapy. Int J Radiat Oncol Biol Phys. 1998;42(3):661-672.
9. Beard CJ, Kijewski P, Bussiere M, et al. Analysis of prostate and seminal vesicle motion: implications for treatment planning. Int J Radiat Oncol Biol Phys. 1996;34(2):451-458.
10. Pinkawa M, Asadpour B, Gagel B, Piroth MD, Holy R, Eble MJ. Prostate position variability and dose-volume histograms in radiotherapy for prostate cancer with full and empty bladder. Int J Radiat Oncol Biol Phys. 2006;64(3):856-861.
11. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: the effective volume method. Int J Radiat Oncol Biol Phys. 1989;16(6):1623-1630.
12. Burman C, Kutcher GJ, Emami B, Goiten M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21(1):123-135.
13. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109-122.
14. Niemierko A. Reporting and analyzing dose distributions: a concept of equivalent uniform dose. Med Phys. 1997;24(1):103-110.
15. Zhang M, Moiseenko V, Liu M, Craig T. Internal fiducial markers can assist dose escalation in treatment of prostate cancer: result of organ motion simulations. Phys Med Biol. 2006;51(2):269-285.
16. Craig T, Moiseenko V, Battista J, Van Dyk J. The impact of geometric uncertainty on hypofractionated external beam radiation therapy of prostate cancer. Int J Radiat Oncol Biol Phys. 2003;57(3):833-842.
17. Carlson DJ, Stewart RD, Li XA, Jennings K, Wang JZ, Guerrero M. Comparison of in vitro and in vivo α/β ratios for prostate cancer. Phys Med Biol. 2004;49(19):4477-4491.
18. Baglan KL, Frazier RC, Yan D, et al. The dose-volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2002;52(1):176-183.
19. Letschert JG, Lebesque JV, Aleman BM, et al. The volume effect in radiation-related late small bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal carcinoma. Radiother Oncol. 1994;32(2):116-123.
20. Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 1998;41(1):83-92.
21. Koper PCM, Stroom JC, van Putten WLJ, et al. Acute morbidity reduction using 3DCRT for prostate carcinoma: a randomized study. Int J Radiat Oncol Biol Phys. 1999;43(4):727-734.
22. Michalski JM, Purdy JA, Winter K, et al. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. Int J Radiat Oncol Biol Phys. 2000;46(2):391-402.
23. Nuyttens JJ, Milito S, Rust PF, Turrisi AT 3rd. Dose-volume relationship for acute side effects during high dose conformal radiotherapy for prostate cancer. Radiother Oncol. 2002;64(2):209-214.
24. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 2000;48(3):635-642.